About: Elsilimomab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Elsilimomab (also known as B-E8) is a mouse monoclonal antibody. B-E8 was developed by Diaclone, a French company which produces many mouse monoclonal antibodies. It (OPR-003) targets (and blocks) Interleukin-6. It has undergone a number of early stage clinical trials, e.g. for lymphoma and myeloma. It was used as a template to develop a high-affinity, antagonist, fully human anti-IL-6 .

Property Value
dbo:abstract
  • إلسيليموماب هو جسم مضاد وحيد النسيلة يطور حالياً في مراحل مبكرة من التجارب السريرية لحالات عديدة مثل الورم اللمفي والورم النقوي المتعدد بصفته دواء كبت مناعة. الدواء مضاد لإنترلوكن-6. (ar)
  • Elsilimomab (also known as B-E8) is a mouse monoclonal antibody. B-E8 was developed by Diaclone, a French company which produces many mouse monoclonal antibodies. It (OPR-003) targets (and blocks) Interleukin-6. It has undergone a number of early stage clinical trials, e.g. for lymphoma and myeloma. It was used as a template to develop a high-affinity, antagonist, fully human anti-IL-6 . (en)
  • Il Elsilimomab o B-E8 è un anticorpo monoclonale di tipo murrino, che viene utilizzato come farmaco immunosoppressivo sperimentale per il linfoma ed il mieloma. Il farmaco agisce sull'Interleuchina-6. (it)
dbo:casNumber
  • 468715-71-1
dbo:fdaUniiCode
  • DGK38A42AE
dbo:wikiPageID
  • 9132879 (xsd:integer)
dbo:wikiPageLength
  • 2929 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1072889048 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • none (en)
dbp:casNumber
  • 468715 (xsd:integer)
dbp:chemspiderid
  • none (en)
dbp:mabType
  • mab (en)
dbp:source
  • o (en)
dbp:target
dbp:type
  • mab (en)
dbp:unii
  • DGK38A42AE (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 457123854 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • إلسيليموماب هو جسم مضاد وحيد النسيلة يطور حالياً في مراحل مبكرة من التجارب السريرية لحالات عديدة مثل الورم اللمفي والورم النقوي المتعدد بصفته دواء كبت مناعة. الدواء مضاد لإنترلوكن-6. (ar)
  • Elsilimomab (also known as B-E8) is a mouse monoclonal antibody. B-E8 was developed by Diaclone, a French company which produces many mouse monoclonal antibodies. It (OPR-003) targets (and blocks) Interleukin-6. It has undergone a number of early stage clinical trials, e.g. for lymphoma and myeloma. It was used as a template to develop a high-affinity, antagonist, fully human anti-IL-6 . (en)
  • Il Elsilimomab o B-E8 è un anticorpo monoclonale di tipo murrino, che viene utilizzato come farmaco immunosoppressivo sperimentale per il linfoma ed il mieloma. Il farmaco agisce sull'Interleuchina-6. (it)
rdfs:label
  • إلسيليموماب (ar)
  • Elsilimomab (en)
  • Elsilimomab (it)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License